View in EDS

A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma.

Saved in:
Bibliographic Details
Title: A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma.
Authors: Turner KA; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: katherineaturner@uabmc.edu., Edwards CC; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: carsoncedwards@uabmc.edu., Ketch PW; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: pketch@uabmc.edu., Dinkins KG; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: kdkincaid@uabmc.edu., Wilbanks A; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: annaburton@uabmc.edu., Leath CA 3rd; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: cleath@uabmc.edu., Arend RC; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: rarend@uabmc.edu., Toboni MD; Division of Gynecologic Oncology, University of Alabama at Birmingham, 1700 6(th) Ave South, Suite 10250, Birmingham, AL 35233, United States. Electronic address: mdtoboni@uabmc.edu.
Source: Gynecologic oncology [Gynecol Oncol] 2026 Jun; Vol. 209, pp. 107-110. Date of Electronic Publication: 2026 May 13.
Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1095-6859
DOI:10.1016/j.ygyno.2026.05.003